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ABSTRACT
Cancer stem cells (CSC) have a central role in driving tumor growth. Since metabolism is becoming an important diagnostic and therapeutic
target, characterization of CSC line energetic properties is an emerging need. Embryonic and adult stem cells, compared to differentiated cells,
exhibit a reduced mitochondrial activity and a stronger dependence on aerobic glycolysis. Here, we aimed to comparatively analyze
bioenergetics features of the human osteosarcoma 3AB‐OS CSC‐like line, and the parental osteosarcoma MG63 cells, from which 3AB‐OS cells
have been previously selected. Our results suggest that 3AB‐OS cells depend on glycolytic metabolism more strongly than MG63 cells. Indeed,
growth in glucose shortage or in presence of galactose or pyruvate (mitochondrial speciﬁc substrates) leads to a signiﬁcant reduction of their
proliferation compared to MG63 cells. Accordingly, 3AB‐OS cells show an increased expression of lactate dehydrogenase A (LDHA) and a larger
accumulation of lactate in the culture medium. In line with these ﬁndings 3AB‐OS cells as compared to MG63 cells present a reduced
mitochondrial respiration, a stronger sensitivity to glucose depletion or glycolysis inhibition and a lessened sensitivity to oxidative
phosphorylation inhibitors. Additionally, in contrast toMG63 cells, 3AB‐OS display fragmentedmitochondria, which become networked as they
grow in glucose‐richmedium, while almost entirely loose these structures growing in low glucose. Overall, ourﬁndings suggest that 3AB‐OS CSC
energy metabolism is more similar to normal stem cells and to cancer cells characterized by a glycolytic anaerobic metabolism. J. Cell. Biochem.
115: 368–379, 2014.  2013 Wiley Periodicals, Inc.
KEY WORDS: CANCER STEM CELLS; CANCER METABOLISM; WARBURG EFFECT
Undifferentiated embryonic stem cells as well as adult stem cellshave recently been shown to have a different energetic
metabolism as compared to fully differentiated cells. In fact, stem
cells rely mostly on anaerobic metabolism rather than on oxidative
phosphorylation (OXPHOS) [Varum et al., 2011]. In addition, it has
been shown that undifferentiated stem cells have a reduced number of
mitochondria, that appear also more immature, a low content of
mitochondrial DNA (mtDNA), a reduced oxygen consumption rate
and a low level of intracellular adenosine triphosphate (ATP) and
reactive oxygen species (ROS) as compared to more differentiated
cells [Chen et al., 2008, 2010]. With regard to this, recent observations
have correlated energetic cell metabolism to self‐renewal and
differentiation potential of stem cells. Moreover, human embryonic
pluripotent stem cells (hESCs) as well as induced pluripotent stem
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cells (iPSCs) show high glycolytic ﬂux [Prigione and Adjaye, 2010;
Prigione et al., 2010], while stem cells, that is, embryonic,
hematopoietic and mesenchymal, that undergo differentiation,
increase mitochondrial biogenesis and function, relying mainly on
OXPHOS for energy supply [Chen et al., 2010]. Accordingly,
inhibition of mitochondrial respiratory chain, which has recently
been found associated with enhancement of hESC pluripotency
[Varum et al., 2009] as well as over‐expression of mitochondrial
protein UCP2 favoring glycolysis, interfere with human PSCs
differentiation [Zhang et al., 2011]. Therefore it is becoming clear
that energetic metabolism could be used for stem cell recognition and
characterization as well as a way of modulating their fate [Chen
et al., 2012].
Cancer stem cells (CSCs) or cancer‐initiating cells are a population
of cells with self‐renewal and differentiation capacity, and for this
reason they are considered similar to normal stem cells [Tang
et al., 2007]. Moreover, CSCs are believed to be fundamental for the
promotion and maintenance of several types of cancer as well as for
acquiring chemo‐ and radio‐resistance and disease recurrence
[O0Brien et al., 2010]. Although our knowledge regarding CSC
biology is still limited, the possibility of using a combination of CSC‐
speciﬁc therapeutic approaches with traditional cancer treatment
strategies is rapidly growing [Clarke and Becker, 2006; Clarke
et al., 2006; Diehn and Clarke, 2006]. Indeed, current therapies
preferentially kill differentiated cancer cells, which eventually may
result in preservation and enrichment of CSCs [Cheng et al., 2011].
Thus, a better understanding of CSC biology is becoming urgent to
provide therapies able to offer signiﬁcant clinical beneﬁt.
To date, several observations have indicated that genetic
alterations that are known to promote cancer lead also to the
reorganization of cell metabolism in order to enhance cell‐
autonomous nutrient uptake and support biosynthesis. In particular
it has been shown that cancer cells use more glucose compared to
normal cells and accumulate extracellular lactate even in normoxic
conditions, a feature called Warburg effect [Chiaradonna et al., 2012;
Ward and Thompson, 2012]. In addition, cancer cells often present a
limited or absent mitochondrial OXPHOS, probably caused by a block
in mitochondrial biogenesis, mtDNA mutations and gene expression
deregulation [Chiaradonna et al., 2012; Ward and Thompson, 2012].
Given that, cancer cell metabolism is being extensively used for
noninvasive diagnostic purposes in several human tumor types,
through the use of positron emission tomography (PET), and is also a
promising approach for cancer therapy. To date, energy metabolism
in CSCs remains to be explored. In fact, it is unknown whether the
metabolic proﬁle of CSCs is similar to that observed in embryonic
stem cells and whether it is able to originate the alterations observed
in somatic cancer cells. Since recent observations indicate a link
between cellular metabolism and cellular differentiation and since
cancer stem cells induced to differentiate become less tumorigenic,
that is, as a consequence of a reduced proliferation [Beug, 2009;
Varum et al., 2009; Zhang et al., 2011], manipulation of cell
metabolism for possible therapeutic targets in tumors is very
intriguing.
So far, the main limitations in studying CSC biology have been
their identiﬁcation, characterization, isolation and mostly important
the fact that they are only a small fraction of the total cancer cells.
Therefore an attractive alternative source of cells for CSC research has
been the identiﬁcation and isolation of established cancer stem cell
subpopulation from cancer cells that retain stem cell patterns of
behavior. Nowadays, CSCs have been successfully separated from cell
lines derived from various solid cancers including glioma [Qiang
et al., 2009], breast cancer [Fillmore and Kuperwasser, 2008], lung
cancer [Ho et al., 2007], head and neck squamous carcinoma [Huang
et al., 2009].
Herein we take advantage of a stable CSC‐like line, namely 3AB‐
OS, derived from a human osteosarcoma cell line MG63 [Di Fiore
et al., 2009]. This CSC‐like line have been shown to express a number
of pluripotent embryonic andmesenchyme stem cell marker genes [Di
Fiore et al., 2009, 2013] and, as conﬁrmed by a transcriptional
proﬁling in comparison with MG63, an enrichment of different
pathways involved in the maintenance of stemness phenotype [Di
Fiore et al., 2013]. Its plurilineage differentiation potential has been
demonstrated in vitro, with the production of derivatives of the three
primary germ layers: endoderm, mesoderm, and ectoderm [Di Fiore
et al., 2013]. Moreover, when injected in athymic mice, these cells
recapitulate various features of human osteosarcoma [Di Fiore
et al., 2012]. Noteworthy is the fact that such a stem‐like phenotype,
both in terms of morphological and antigenic features, is retained
after prolonged serial passages (up to now, more than 200 passages)
(unpublished observations). In our study we show that 3AB‐OS cells
rely on glycolysis to sustain their proliferation and survival. Indeed,
glucose deprivation and glycolysis inhibition induce their prolifera-
tion arrest and death. Importantly, analysis of some mitochondrial
parameters, like respiration rate, mitochondrial genes expression,
OXPHOS‐dependent ATP production andmitochondrialmorphology,
indicate that they are more similar either to normal stem cells or to
cancer cells characterized by a glycolytic anaerobic metabolism.
MATERIALS AND METHODS
CELL CULTURES
Human osteosarcoma MG63 cells and 3AB‐OS stem cells [Di Fiore
et al., 2009] were routinely cultured in Dulbecco0s modiﬁed Eagle0s
medium (DMEM) containing 4mM L‐glutamine, 100U/ml penicillin
and 100mg/ml streptomycin (complete medium), supplemented with
10% Fetal Bovine Serum. All reagents for media were purchased from
Life Technologies (Carlsbad, CA).
CELL ANALYSES AND TREATMENTS
Cells were plated at the density of 12,500 cells/cm2 in complete
growth medium. After 16 h cells were washed twice with phosphate
buffer saline (PBS) and incubated in growth medium (time 0) without
glucose and sodium pyruvate (Life Technologies), supplemented with
25 or 1 or 0.25mM glucose, 25mM galactose, 10mM methyl‐
pyruvate, 25mM glucose supplemented with 5 or 10mg/ml oxamate.
Glucose, galactose, methyl‐pyruvate and oxamate were purchased
from Sigma‐Aldrich, Inc. (St. Louis, MO). For some speciﬁc analyses,
cells at time 0 were incubated in growth medium with 25mM glucose
supplemented with 4 or 0.5mM glutamine (Life Technologies). Cells
were then collected for further analyses at 24, 48, 72 h of culture.
When indicated, viable cell count was performed using Trypan Blue
Stain 0.4% (Life Technologies).
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D‐GLUCOSE AND LACTATE MEASUREMENT
D‐Glucose and L‐Lactate levels in culture medium were determined
using spectrophotometric enzyme assay kits (R‐Biopharm, Darm-
stadt, Germany) as speciﬁed by manufacturer0s datasheet.
FLOW CYTOMETRIC ANALYSES
Cell death and glucose uptake analyses were carried out through ﬂow
cytometric analyses using a FACScan ﬂow cytometer (Becton‐
Dickinson, Franklin Lakes, NJ) with CellQuest software (Becton‐
Dickinson). Cell death was analyzed by staining cells with Annexin
V‐FITC and propidium iodide (PI) through the Apoptosis assay kit
from Immunological Sciences (Rome, Italy). Glucose uptake assay
was performed using 2‐[N‐(7‐nitrobenz‐2‐oxa‐1,3‐diazol‐4‐yl) ami-
no]‐2‐deoxy‐D‐glucose (2‐NBDG; Life Technologies) ﬂuorescent
glucose analogue as described in Palorini et al. [2013]. Analysis of
ﬂow cytometric data was carried out using WinMDI software (freely
available).
INTRACELLULAR ATP ANALYSIS
Intracellular ATP levels were measured using CellTiter Glo® luciferin‐
luciferase assay (Promega, Madison, WI) as described in Chiaradonna
et al. [2006b]. Where indicated, intracellular ATP levels were
measured after 1 or 2 h cell treatment with 5mM oligomycin
(Sigma‐Aldrich) or 3 nM rotenone (Sigma‐Aldrich).
OXYGEN CONSUMPTION RATE (OCR) ANALYSIS
Oxygen consumption was determined using Seahorse XF24 extra-
cellular Flux analyzer (Seahorse Bioscience, North Billerica, MA).
Brieﬂy, cells for the analysis were seeded in a dedicated 24‐well XF24
cell culture plate in a complete medium. Then, 1 h before the analysis,
this culture medium was exchanged for a speciﬁc base medium
(unbuffered DMEM supplemented with 25mM glucose and 2mM
sodium pyruvate) to be used along all the experiment. Different
compounds were added in succession: oligomycin (1mM), carbonyl
cyanide 4‐(triﬂuoromethoxy)phenylhydrazone (FCCP) (0.9mM) and
rotenone (1mM) plus antimycin A (1mM). The compounds were
purchased as XF Cell Mito Stress Test kit from Seahorse Bioscience.
After the analysis the cells were ﬁxed, stained with Crystal Violet and
dosed at spectrophotometer after colorant solubilization with acetic
acid 10%; all OCR values obtained by the instrument were normalized
on cell density. Due to some variations in the absolute magnitude of
OCR measurements in different experiments, the relative OCR levels
were used to compare and summarize independent biological
replicates. Coupling efﬁciency and spare respiratory capacity were
calculated as 1 minus (response to oligomycin/basal respiration) and
response to FCCP/basal respiration, respectively. Response to
oligomycin represents the minimum rate after oligomycin injection;
response to FCCP represents the maximum rate after FCCP injection;
basal respiration is the third basal measurement (before the ﬁrst
injection).
OXPHOS COMPLEX I ACTIVITY DETERMINATION
To determine the complex I activity the Complex I Enzyme Activity
Microplate Assay kit from Abcam (Cambridge, UK) was used.
The analysis was performed following manufacturer0s datasheet
and using for each determination 0.6mg of whole culture cell
extract.
GENE EXPRESSION ANALYSIS BY qPCR
RNA was extracted from cells using Trizol reagent (Life Technologies
Corporation). Total RNA was reverse transcribed with oligo dT by
using the Superscript™ III RT‐PCR First Strand Synthesis System for
RT PCR (Life Technologies Corporation). 0.2mg of the RT product was
ampliﬁed by real‐time quantitative PCR (qPCR) with an Applied
Biosystem 7500 standard system (Life Technologies Corporation)
using POWER SYBR GREEN PCR mix for qPCR (Life Technologies
Corporation). Primers were designed using Primer3Plus software
(http://www.bioinformatics.nl/cgi‐in/primer3plus/primer3plus.cgi)
and used at 0.25mM. The analysis was performed for some glycolytic
genes (GLUT1, HKII, LDHA), Complex I genes (NDUFA9, GRIM19,
and ND1), Complex IV genes (COXI, COXII, COXIII, and COXIV) and
Complex V genes (ATP5B and ATP6). As internal control of PCR
assays speciﬁc primers for beta‐actin transcript were designed.
Primers: GLUT1: forward CTCCCCACACACACAAAA, reverse
CCAAATCGGCATCTTCTCAT; HKII: forward TAGGGCTTGAGAG-
CACCTGT, reverse CCACACCCACTGTCACTTTG; LDHA: forward
TGTGCCTGTATGGAGTGGAA, reverse AGCACTCTAACCACCTGCT;
NDUFA9: forward CAGATTGTTCCTCCCATTCC, reverse TGCA-
TCCGCTCCACTTTATC; GRIM19: forward AGATGCTTCGGGA-
GAACCTG, reverse GGCCTACGTGTACCACATGA; ND1: forward
CCCTGGTCAACCTCAACCTA, reverse CTAGTTCGGACTCCCCTTCG;
COXI: forward ACGTTGTAGCCCACTTCCAC, reverse AGCGAA-
GGCTTCTCAAATCA; COXII: forward TAACATCTCAGACGCTCA-
GGAA, reverse GTTGAAGATTAGTCCGCCGTAG; COXIII: forward
AAATCCCCTAGAAGTCCCACTC, reverse CTCTGAGGCTTGTAG-
GAGGGTA; COXIV: forward TTCGCTCCCAGCTTATATGG, reverse
GCTTCTGCCACATGATAACG; ATP5B: forward TTGCTATGGATGG-
TACAGAAGG, reverse TTTGGTTTTGATGGGACCTC; ATP6: forward
TATTGATCCCCACCTCCAAA, reverse GATGGCCATGGCTAGGTTTA;
ACTIN B: forward TCATGAAGTGTGACGTTGACA, reverse CCTA-
GAAGCATTTGCGGTGCAC.
WESTERN BLOT
For the analysis of glycolytic proteins, cells were harvested and lysed
in JS buffer (50mM Hepes pH 7.5, 150mM NaCl, 1% glycerol; 1%
triton X‐100, 1.5mM MgCl2, 5mM EGTA). For each sample an equal
amount of the whole extract was then resolved by sodium dodecyl
sulfate polyacrylamide gel electrophoresis and transferred to
nitrocellulose membrane, which was incubated overnight with
antibodies for GLUT1 (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA), HKII and Actin B (Cell Signaling Technology, Inc., Danvers, MA)
and LDHA (CHEMICON by EMDMillipore Corporation, Billerica, MA).
MITOCHONDRIAL MORPHOLOGY ANALYSIS
To study mitochondrial morphology, stable cell clones of MG63 and
3AB‐OS, expressing a pEYFP‐Mito fusion protein (6115‐1, BD
Biosciences, Franklin Lakes, NJ) were isolated and used for the
morphological experiments. Images of mitochondrial morphology
were collected under a Nikon ECLIPSE 90i ﬂuorescence microscope
(Nikon, Tokyo, Japan) equippedwith a b/w CCD camera (Hamamatsu‐
CoolSnap, Hamamatsu Corporation, Japan). Images were then
visualized, processed and classiﬁed by using ImageJ software.
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RESULTS
3AB‐OS CANCER STEM CELLS ARE STRONGLY DEPENDENT ON
GLUCOSE AVAILABILITY FOR CELL PROLIFERATION AND SURVIVAL
As reported by several Authors, cancer cells are more susceptible, in
terms of proliferation and cell death, to glucose (Glc) or glutamine
(Gln) withdrawal as compared to normal counterparts [Chiaradonna
et al., 2006b; Yuneva et al., 2007]. Thus, we decided to analyze cell
proliferation of the MG63 and 3AB‐OS cell lines in different initial
glucose and glutamine concentrations: normal glucose and gluta-
mine condition (25mM Glc plus 4mM Gln); low glucose condition (1
or 0.25mMGlc plus 4mM Gln); low glutamine condition (25mM Glc
plus 0.5mM Gln). Although glucose shortage halted proliferation in
both cell lines, as shown by cell counting (Fig. 1A,B), it induced
speciﬁcally cell death in 3AB‐OS cells, as shown by microscopy
observation (ﬂoating rounded cells are seen) (Fig. 1C), Trypan Blue
vital stain (Fig. 1D,E) and Annexin V/PI staining followed by FACS
analysis (Fig. 1F,G). In particular, the latter analysis, performed at
72 h of growth in low glucose, indicated a threefold increase of
percentage of cell death in 3AB‐OS cells as compared toMG63 (42.3%
vs. 13.5%, upper right and left quadrants and lower right quadrant).
Importantly, such an increase of cell death was appreciably glucose‐
dependent only in 3AB‐OS cells, since the percentage measured at
normal glucose was 11.1% in this cell line and 6.1% in MG‐63 cells.
To certainly correlate the effects on cell proliferation and survival
to glucose withdrawal, we measured the residual glucose in the
low glucose culture medium along a time course of 72 h. As shown
in Supplementary Figure 1, both cell lines utilized all the glucose
present in the medium in 24 h, suggesting that after that time
they had to use different substrates for their anabolic and energetic
needs.
Several studies have reported that glucose deprivation can lead to
ATP depletion leading cell death [Chiaradonna et al., 2006b; Kim
et al., 2007; Sandulache et al., 2011; Palorini et al., 2013]. Therefore
we determined the levels of ATP in both cell lines grown in the normal
condition and in glucose shortage along a time course of 72 h. Overall,
slightly higher ATP levels were observed in MG63 cells as compared
to 3AB‐OS cells along the time course (Fig. 1H). In particular, at the
later time point of low glucose growth (72 h), in correlation with the
appearance of cell death, 3AB‐OS cells showed a signiﬁcant decrease
in ATP levels as compared to the high glucose condition and to MG63
cells grown in the same glucose availability (Fig. 1H). Notably, all the
glucose‐dependent effects observed in 3AB‐OS cells were further
increased at 96 h of culture (data not shown) underlining the
important role of the glucose in CSC physiology.
Since many cancer cells depend on glutamine as a fuel for growth,
we also tested the effect of glutamine reduction on both cell line
proliferation. As shown in Supplementary Figure 2, glutamine
withdrawal induced a slight decrease of proliferation only in MG63
cells at 72 h of culture.
Altogether these ﬁndings suggest that 3AB‐OS cells are strongly
dependent on glucose availability for their proliferation and survival
as compared to MG63 cells. In addition we observe that MG63
cells are more sensitive to glutamine deprivation, indicating that
glutamine is much critical for their growth as compared to 3AB‐OS
cells.
LACTATE DEHYDROGENASE INHIBITION ROBUSTLY AFFECTS
3AB‐OS PROLIFERATION AND SURVIVAL
In order to investigate whether the 3AB‐OS proliferation arrest and
death in low glucose could be a consequence of alterations in glucose
metabolism, we assessed several glycolytic parameters by measuring
the glucose transport rate into the cells, glucose consumption and
lactate production, the mRNA and protein expression of some
glycolytic proteins and the effects of the treatment with oxamate, a
known lactate dehydrogenase A (LDHA) inhibitor. Glucose uptake
rate was measured by using the ﬂuorescent derivative of glucose 2‐
NBDG as indicator. Such an analysis, performed on cells grown for
24 h of culture in high glucose condition, indicated a slightly faster
uptake in MG63 cells as compared to 3AB‐OS (Fig. 2A). To further
detail the glycolytic capacity of both cell lines, glucose utilization and
lactate production in cells grown at high glucose availability were
assayed. As shown in Figure 2B, the amount of consumed glucose per
cell, at both 24 and 72 h of culture, was substantially comparable
between the two cell lines; however, 3AB‐OS cells produced, at both
time points, a larger amount of lactate as compared to MG63 cells
(Fig. 2C). To investigate whether the different fate of glucose, as
indicated by the increased lactate production of 3AB‐OS cells, could
be associated with a different expression of glycolytic proteins in the
two cell lines, we measured both mRNA and protein expression levels
of the glucose transporter GLUT1, of the enzyme catalyzing the ﬁrst
glycolytic step, namely Hexokinase II (HKII) and of the pyruvate‐
lactate converting enzyme LDHA. As shown in Supplementary
Figure 3, the mRNA level of HKII was higher in 3AB‐OS cells. No
difference in GLUT1mRNA expression was observed between the two
cell lines. Conversely, GLUT1 proteinwas higher expressed in 3AB‐OS
cells as compared to MG63 and no difference in HKII protein
expression was observed (Supplementary Figure 3). Notably, a clear
increase of LDHA mRNA and protein expression in 3AB‐OS cells as
compared to MG63 was observed (Fig. 2D). Since the key glycolytic
enzyme LDHA was highly expressed in 3AB‐OS cells we sought to
determine if 3AB‐OS cells proliferation and survival could be altered
by inhibiting LDHA activity using oxamate, a structural analog of
pyruvate that acts as competitive inhibitor of LDHA. As shown in
Figure 2E, F, oxamate addition to the culture medium induced in
3AB‐OS cells a time‐ and dose‐dependent cell death process that was
not observed in MG63 cells.
Thus, these data show that 3AB‐OS cells, despite the similar
glucose consumption and the slightly lower rate of glucose uptake as
compared to MG63 cells, are fundamentally dependent on glucose
fermentation for proliferation and survival. In addition, the data
underline the ability of MG63 cells to activate other metabolic
processes, that is, oxidative phosphorylation, that guarantee their
survival under glucose shortage.
3AB‐OS CELLS SHOW REDUCED MITOCHONDRIAL RESPIRATION
AND COMPLEX I ACTIVITY AS COMPARED TO MG63 CELLS
ASSOCIATED TO LIMITED ALTERATIONS OF mRNA EXPRESSION OF
OXPHOS GENES
To test whether high sensitivity to aerobic glycolysis inhibition in
3AB‐OS cells is a consequence of a reducedmitochondrial activity, we
assessed the ability of both cell lines to grow in media containing
galactose or pyruvate. In fact, both substrates in a glucose‐free
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medium would favor mitochondrial oxidative respiration over
glycolysis. MG63 cells, grown in media containing 1mM glucose,
25mM galactose or 10mM methyl‐pyruvate, exhibited a similar rate
of proliferation (Fig. 3A,C,D). Conversely, galactose‐ and pyruvate‐
enriched growth media further decreased 3AB‐OS proliferation, as
compared to low glucose, since an early reduction in the slope of
the growth curve (24 h) was observed (Fig. 3B–D). To measure the
fraction of total ATP generated by mitochondrial OXPHOS under
the prevailing cultivation conditions, the cells were treated with
oligomycin, a speciﬁc inhibitor of the mitochondrial FoF1 ATP
Fig. 1. Glucose deprivation leads to 3AB‐OS cell proliferation arrest and death associated with intracellular ATP depletion. Proliferation curves of MG63 (A) and 3AB‐OS (B) cells
cultured at 25, 1, or 0.25mM glucose were determined counting cells at indicated time points. C: Phase contrast microscopy images were collected for MG63 and 3AB‐OS cells at
72 h of cell culture. D,E: The percentage of MG63 (D) and 3AB‐OS (E) cell death at the different culture conditions was evaluated by using Trypan Blue Stain; P< 0.05, P< 0.01
and § not signiﬁcant (Student0s t‐test), compared to 25mM glucose. F,G: Apoptosis was also evaluated at 72 h of culture by staining MG63 (F) and 3AB‐OS (G) cells with Annexin
V‐FITC and PI. Representative dot plots are shown. H: Also total intracellular ATP was measured in both cell lines; #P< 0.001 and § not signiﬁcant (Student0s t‐test). All data
represent the average of at least three independent experiments (SD).
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synthase, and rotenone, a mitochondrial Complex I inhibitor. The
addition of oligomycin and rotenone respectively reduced the
intracellular ATP level of MG63 cells by around 15% and 12% in
1 h and 26% and 20% in 2 h (Fig. 3E,G). In 3AB‐OS cells, cultivated in
the same condition, oligomycin and rotenone addition did not exert a
major inhibitory effect on cellular ATP levels (around 5% for both) as
compared to MG63 cells (Fig. 3F,G) and as compared to the oxamate
effect (data not shown). These ﬁndings show that in 3AB‐OS cells the
mitochondrial OXPHOS contributes only marginally to cellular ATP
production, which is essentially contributed by glycolysis. Altogether
these ﬁndings conﬁrm the low functioning of 3AB‐OS mitochondria,
resulting in the inability to grow on speciﬁc respiratory substrates as
compared to MG63 cells.
To directly determine the mitochondrial activity of 3AB‐OS cells
compared to MG63 cells we performed the analysis of the oxygen
consumption rate (OCR) using the Seahorse XF24 extracellular ﬂux
analyzer. In particular, we determined a response proﬁle to speciﬁc
compounds that are able to shift cell bioenergetics. The complete
proﬁle conﬁrmed that 3AB‐OS cells have reduced mitochondrial
respiration as compared with MG63 (Fig. 4A). In fact, 3AB‐OS cells
showed a lower coupling efﬁciency (Fig. 4B), calculated after the
treatment with oligomycin, and lower spare respiratory capacity (the
maximal capacity of themitochondrial OXPHOS), calculated after the
treatment with FCCP (Fig. 4C). Both parameters are a distinct
indication of a lower mitochondrial activity in 3AB‐OS cells as
compared to MG63 ones.
Since several authors have shown in different cancer cells a
relation between mitochondrial dysfunction and alteration in the
levels of expression of nuclear or mitochondrial genes encoding for
OXPHOS complexes [Park et al., 2009; Gasparre et al., 2011] or
reduction of Complex I activity [Baracca et al., 2010], we speciﬁcally
determined the enzymatic activity of Complex I and the level of
expression of some mRNAs encoding for mitochondrial Complex I,
IV, and V subunits in both cell lines.
As shown in Figure 4D, 3AB‐OS cells, in line with their reduced
OCR value, showed also a reduction of Complex I activity of about
40% as compared to MG63 cells. Surprisingly, despite the strong
reduction of Complex I activity, two on three mRNA encoding for
Fig. 2. Higher expression of LDHA in 3AB‐OS cells leads to a major use of glucose through fermentation rather than through OXPHOS. A: Glucose uptake rate was determined by
using the ﬂuorescent glucose analogue 2‐NBDG at 24 h of culture; P< 0.05 (Student0s t‐test). B,C: Residual glucose (B) and secreted lactate (C) in the culture medium of MG63
and 3AB‐OS cells, grown at 25mM initial glucose concentration, were measured by using speciﬁc enzymatic kits. The obtained values were used to calculate the consumed glucose
and the produced lactate per cell at indicated time points; P< 0.05 (Student0s t‐test). D: mRNA and protein expression of Lactate dehydrogenase A (LDHA) in MG63 and 3AB‐OS
cells was determined by real‐time qPCR and Western blot, respectively. mRNA expression levels in 3AB‐OS cells are reported as change (n‐fold) with respect to the amount of
relative mRNA expressed in MG63 cells, using beta‐actin mRNA as an internal control. Protein level in 3AB‐OS is reported as fold change over the expression level in MG63 cells,
using Actin for the normalization. On the right a representative image of the Western blot is reported. P< 0.05 (Student0s t‐test). E,F: MG63 (E) and 3AB‐OS (F) cells were
cultured at 25mM glucose in presence of the glycolysis inhibitor oxamate and counted at the indicated time points using Trypan Blue Stain. In the histograms the number of alive
cells at each time point is represented as fold change over time 0; P< 0.01, #P< 0.001 and § not signiﬁcant (Student0s t‐test), compared to time 0. All data represent the average
of three independent experiments (SD).
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Complex I subunits (NDUF9 and ND1 vs. GRIM19) were strongly
overexpressed in 3AB‐OS cells as compared to MG63 ones (Fig. 4E).
On the contrary, no signiﬁcant differences between the two cell lines
in the expression levels of the Complex IV (COX I, COX II, COX III,
and COX IV) and Complex V (ATP5B and ATP6) tested mRNAs
were observed (Fig. 4E).
3AB‐OS CELLS SHOW MORE FRAGMENTED MITOCHONDRIAL
MORPHOLOGY ESPECIALLY UPON NUTRIENT DEPLETION
Mitochondria are dynamic organelles that mediate several cell
functions. Depending on the cellular context, mitochondria may
shift between fragmented and networked structure by means of
coordinated ﬁssion and fusion [Westermann, 2010]. Given that, it has
been shown that interconnected mitochondria are functionally more
active than fragmented mitochondria [Mitra et al., 2009; Gomes
et al., 2011]. Therefore we sought to determine mitochondrial
morphology of both cell lines, along a time‐course in normal growth
conditions and in low glucose, that is known to induce mitochondrial
elongation [Rambold et al., 2011; Palorini et al., 2013].
Mitochondrial morphology was analyzed by means of stable
clones of both cell lines expressing a mitochondrially targeted EYFP‐
Mito protein (Fig. 5A). Three types of mitochondrial morphologies
have been classiﬁed as fragmented, intermediate and networked
(Fig. 5A). At an early growth time (0–24 h), MG63 cells displayed
especially networked and intermediate mitochondria regardless of
initial glucose concentrations (Fig. 5B). At a later growth time (72 h),
mitochondrial morphology was strictly associated with glucose
availability. In fact, in glucose rich medium, MG63 cells showed a
Fig. 3. 3AB‐OS cells are unable to proliferate in presence of respiratory substrates. Proliferation curves of MG63 (A) and 3AB‐OS (B) cells cultured at 25mM glucose (Glc), at
1mM Glc, at 25mM galactose (Gal) or 10mM methyl‐pyruvate (Pyr) were determined counting cells at the indicated time points. C,D: Percentages of proliferation reduction in
25mM Gal (C) and 10mM Pyr (D) as compared with 25mM Glc at each time point for both cell lines. E,F: Total intracellular ATP levels were measured in MG63 (E) and 3AB‐OS (F)
cells grown for 24 h at 25mM Glc, treated or not with 5mM oligomycin or 3 nM rotenone for 1 or 2 h. Values are relative to untreated samples. G: Percentage of ATP reduction as
compared to untreated samples for both cell lines upon the above treatments. All data represent the average of at least three independent experiments (SD); P< 0.05,
P< 0.01, #P< 0.001 and § not signiﬁcant (Student0s t‐test).
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slight reduction of networked mitochondria, while in low glucose
they showed a completely disappearance of fragmentedmitochondria
in favor of more interconnected mitochondria (Fig. 5B). Similar
analyses in 3AB‐OS cells indicated a completely opposite behavior. In
fact, at an early growth time (0–24 h), 3AB‐OS displayed especially
fragmented mitochondria (Fig. 5C). At the later growth time (72 h), in
glucose‐rich medium, intermediate and networked mitochondria
increased (Fig. 5C), while in low glucose these structures were almost
lost with a parallel increase of fragmented mitochondria (Fig. 5C,
right panel). Taken together, these results further conﬁrm the
differences between these two cell lines regarding mitochondrial
function, and highlight the inability of 3AB‐OS cell mitochondria to
elongate under glucose starvation.
DISCUSSION
We have sought to deﬁne the energetic metabolism of the CSC‐like
line, 3AB‐OS, as compared to its osteosarcoma cancer cells of origin,
MG63. It is interesting to note that MG63 cells have both mature and
immature osteoblastic features [Pautke et al., 2004]. We started our
analysis by measuring their ability to proliferate and survive in low
glucose or glutamine availability, since both nutrients have been
shown to be necessary for cancer cell proliferation and survival
[Chiaradonna et al., 2006b; Yuneva et al., 2007; Palorini et al., 2013].
In addition, recent reports have shown that human pluripotent stem
cells rely mostly on glycolysis to meet their energy demands [Chen
et al., 2010; Prigione et al., 2010] and that osteogenic differentiation
Fig. 4. 3AB‐OS have lower oxygen consumption rate and Complex I activity as compared to MG63. A: Oxygen consumption rate (OCR) was determined by Seahorse XF24
Extracellular Flux Analyzer, as described inMaterials andMethods Section, under basal conditions and after adding oligomycin, FCCP and rotenone plus antimycin A (as indicated by
the arrows). The coupling efﬁciency (B) and the spare respiratory capacity (C) were calculated for each sample by using the OCR values generated by Seahorse dedicated software. All
data represent the average of three independent experiments and 15 total samples (SEM); P< 0.01 and #P< 0.001 (Student0s t‐test). D: Complex I activity was measured in
whole protein extracts of MG63 and 3AB‐OS and plotted as relative to the value obtained in MG63 cells. Data represent the average of three independent experiments ( SD);
#P< 0.001 (Student0s t‐test). E: Analysis of genes encoding respiratory chain subunits in 3AB‐OS andMG63 cells were determined by real‐time qPCR using beta‐actin mRNA as an
internal control. Levels of expression in 3ABOS cells are reported as change (n‐fold) with respect to the amount of relative mRNAs expressed in MG63 cells. Data represent the
average of three independent experiments (SD).
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of human mesenchimal stem cells (hMSCs) is characterized by an
increase in the respiratory activity [Sanchez‐Arago et al., 2013]. Our
results clearly indicate that 3AB‐OS cells have an energetic
metabolism similar to cancer cells and pluripotent stem cells and
different to the osteosarcoma cancer cells of origin MG63. Indeed
when they are subjected to glucose deprivation, they ﬁrst undergo cell
proliferation arrest, as observed in MG63 cells, and then, upon
prolonged glucose starvation, cell death. Of interest is the fact that
both cell lines, when grown in 25mM glucose, consume a similar
amount of glucose per cell. Despite these results, 3AB‐OS accumulate
a larger amount of lactate in the external medium, implying a more
fermentative consumption of glucose as compared to MG63 cells.
These observations, therefore, suggest that MG63 cells are more able
to use glucose or other substrates through mitochondrial OXPHOS
than fermentative glycolysis. In accordance, upon glutamine
shortage the proliferation of MG63 is slightly inhibited. The elevated
glycolysis in 3AB‐OS cells is conﬁrmed by the higher expression of
the essential glycolytic enzyme LDHA and by the observation that
LDHA inhibition signiﬁcantly induces 3AB‐OS cell death. Notable, as
indicated before, despite a stronger dependence of 3AB‐OS cells from
glucose availability, the rate of glucose uptake in this cell line is
slightly lower as compared to MG63 cells. This result is in part
unexpected taking in consideration that several reports have shown
an increased expression of glucose transporters and glucose uptake in
cancer cells [Rodriguez‐Enriquez et al., 2009]. However, these
ﬁndings are in agreement with a previously published transcriptional
proﬁling analysis performed in MG63 and 3AB‐OS cells grown in
25mM glucose [Di Fiore et al., 2013]. In fact, it has been shown a
down‐regulation of two glucose transporters, namely SLC2A10 and
SLC2A12, in 3AB‐OS cells as compared to MG63 [Di Fiore
et al., 2013]. Therefore, despite a higher expression of GLUT1 in
3AB‐OS cells, we cannot exclude that other glucose transporters are
more expressed in MG63 cells. Additionally reduced glucose
consumption in lung CSCs as compared to lung cancer cells [Ye
et al., 2011] or lower ﬂuorodeoxyglucose (FDG) uptake in osteosar-
coma stem cell‐like line compared to its parental osteosarcoma cell
line [Martins‐Neves et al., 2012] has been also observed. This effect
has been suggested to be consequent either to a reduced energy
requirement of more quiescent cells, like stem cells, or to a more
undifferentiated state, since glucose consumption and FDG uptake
increase when they have been cultured in a differentiation medium
[Ye et al., 2011; Martins‐Neves et al., 2012]. Moreover, from our data
we can argue that themain difference between the two cell lines is not
the rate of glucose uptake but its fermentative fate through glycolysis
Fig. 5. 3AB‐OS cells upon glucose depletion are unable to network mitochondria. A: Examples of fragmented, intermediate and networked mitochondria in stable EYFP‐Mito
expressing MG63 (upper panels) and 3AB‐OS cells (lower panels). B,C: Analysis of mitochondrial morphology in MG63 (B) and 3AB‐OS (C) cells grown at 25 and 1mM glucose for
72 h. For each determination, at least 100 cells were counted and classiﬁed depending their mitochondrial morphology. Data represent the average of at least three independent
experiments (SD).
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in 3AB‐OS cells and its greater respirative fate through OXPHOS in
MG63 cells. These data are supported also by the reduced respirative
metabolism of 3AB‐OS cells as compared toMG63. Indeed, growth on
more respiratory substrates like galactose and pyruvate as well as the
low effect on intracellular ATP levels of oligomycin and rotenone,
known mitochondrial inhibitors, indicate a higher dependence on
glycolysis as compared to MG63 cells. Additionally, the reduced
oxygen consumption rate of 3AB‐OS cells and the signiﬁcant
reduction of Complex I activity convincingly imply that also this CSC
like line has a metabolism similar to SCs. In fact, as described in the
ﬁrst section, it has been shown that repression and activation of the
mitochondrial functions are critical for the self‐renewal and
differentiation of hESCs, respectively. Various authors have shown
that ESCs before spontaneous differentiation, or as compared to
differentiated cardiomyocytes, show a lower mitochondrial mass, a
lower mtDNA copy number as well as lower ATP content [Facucho‐
Oliveira et al., 2007; Facucho‐Oliveira and St John, 2009; Hom
et al., 2011]. Similar evidence has been observed also in HSC and
MSC. Indeed the former cells show a reduced amount of mitochondria
and lowmitochondrial respiration [Piccoli et al., 2005] while the latter
show a higher dependence on glycolysis for energy but rapidly shift to
aerobic mitochondrial metabolism once they are induced to undergo,
that is, osteogenic differentiation [Chen et al., 2008]. In this scenario,
our ﬁndings assume an important meaning considering that
undifferentiated pluripotent stem cells, which preserve their ability
to renew themselves, show an anaerobic metabolism. Therefore, the
ability in keeping a low energetic mitochondrial metabolismmay also
favor in cancer stem cells an undifferentiated state and the ability to
renew. These are fundamental characteristics associated with their
high tumorigenic potential [Kelly et al., 2007]. Despite the reduced
mitochondrial activity, 3AB‐OS cells showed a higher expression of
mitochondrial genes encoding for Complex I subunits, namely
NDUFA9 and ND1. This result was in part unexpected since previous
data obtained in ESCs as well as in lung cancer‐stem like cells have
shown in both cells a reduced amount of mtDNA as compared to
differentiated cells or A549 cancer cells, respectively [Cho et al., 2006;
Ye et al., 2011]. However, recently, also other authors have observed
that pluripotent cells present higher protein levels of mitochondrial
complexes than differentiated cells, although they show a lower
OXPHOS activity and rely mostly on glycolysis to meet their energy
demands [Varum et al., 2011]. Moreover, Warburg effect in cancer
cells is often accompanied by the lack of functional or well‐assembled
Complex I as consequence of point‐mutations or mRNA expression
deregulation in the genes encoding for subunits of this complex
[Faure Vigny et al., 1996; Baracca et al., 2010]. Nevertheless, it has
been also demonstrated that mtDNA mutations compromising both
activity and assembly of OXPHOS complexes may decrease or even
inhibit tumor growth in xenograft models [Park et al., 2009; Gasparre
et al., 2011]. Given our results and the fact that the mechanisms
leading to metabolic rewiring in CSCs remain largely unknown, we
cannot exclude that such an increased expression would favor
aerobic glycolysis. In the future further studies are needed, in
particular it will be necessary to compare 3AB‐OS cells to other
osteosarcoma cell lines, that is, U2OS as well as to ESCs. On the other
hand, morphological analysis of 3AB‐OSmitochondria, at the normal
growth condition, indicated that they were more fragmented and
perinuclear distributed as compared to MG63 cells. This result further
supports a reduced mitochondrial activity, since such a morphology
has been observed in ESCs, iPSCs, CSCs, and in several glucose‐
addicted cancer cells, which are all characterized by OXPHOS
impairment [Chiaradonna et al., 2006a; Mandal et al., 2011; Ye
et al., 2011; Palorini et al., 2013]. Notable is that such an immature
morphology evolves into ﬁlamentous networks of elongated and
branched mitochondria when stem cells undergo differentiation
[Mandal et al., 2011]. Our data indicated that 3AB‐OS cells changed
spontaneously mitochondrial morphology, increasing the percentage
of more interconnected mitochondria, when grown in optimal
conditions for at least 72 h. Since this observation could suggest a
partial spontaneous differentiation of 3AB‐OS, in the future it will be
interesting to correlate mitochondrial morphology with staminal
markers as OCT4 or NANOG as well as to correlate mitochondrial
activity with 3AB‐OS differentiation. In fact, it is worth noting that
these cells, upon established protocols, may be induced to
differentiate in different types of cells such as osteoblasts and
adipocytes (unpublished observations). Moreover it has also been
shown that in ESCs there is a link among mitochondrial function,
proliferation and self‐renewal. In fact, in these cells, the inhibition of
the mitochondrial function induces a retard of the proliferation of
self‐renewing cells, which becoming more glycolysis‐dependent
express pluripotent markers at a level even higher than their normal
counterparts [Mandal et al., 2011]. Therefore, up to now we cannot
exclude that 3AB‐OS cells may partially sustain a mitochondrial
function, perhaps for an anabolic more than an energetic purpose, to
maintain their proliferation capacity. In conclusion, our data indicate
that 3AB‐OS cells rely mostly on glycolysis for their proliferation,
survival and ATP production. In addition we clearly show that these
cells have a reduced mitochondrial function and different mitochon-
drial morphology as compared to MG63 cells. Altogether these data
conﬁrm that CSCs have an energetic metabolism similar to either
normal tissue stem cells [Varum et al., 2011] or to high glycolytic
cancer cells [Chiaradonna et al., 2012; Ward and Thompson, 2012]. A
better deﬁnition of the differences between CSCs and cancer cells will
help the development of novel therapeutic strategies.
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